Fundz

Cadrenal Therapeutics reported raising $7.92 Million in an initial SEC Form D filing, from an offering of $7.92 Million

PUBLIC · CVKDApr 06, 2026

Amount Raised

$7.92 Million

$7.92 Million per company press release (Jul 1, 2026)

Round Type

Series C

Ponte VedraBiotechnology

Description

Cadrenal Therapeutics has announced a definitive agreement for a $3 million private placement with a healthcare-focused institutional investor. The deal includes warrants that could yield an additional $5.8 million. These proceeds are intended to extend the company's cash runway into 2027 for their products targeting rare diseases. H.C

Quick answer

Cadrenal Therapeutics raised $7.92 Million in a Series C round, dated April 1, 2026. Cadrenal Therapeutics is based in Ponte Vedra, Florida, United States.

How much did Cadrenal Therapeutics raise?
Cadrenal Therapeutics raised $7.92 Million in a Series C round on April 1, 2026.
What does Cadrenal Therapeutics do?
Cadrenal Therapeutics is a late-stage biopharmaceutical company developing tecarfarin, an oral therapeutic designed to be a superior and safer Vitamin K antagonist (VKA) anticoagulant for patients with implanted cardiac..
Where is Cadrenal Therapeutics based and how big is it?
Cadrenal Therapeutics is based in Ponte Vedra, Florida, United States. Fundz records about 5 employees.
Who are the decision-makers at Cadrenal Therapeutics?
Fundz holds 2 contacts at Cadrenal Therapeutics, including the Chief Financial Officer. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Biotechnology around the same time

Companies in the same sectors as Cadrenal Therapeutics that raised within 45 days of this round, from Fundz verified event records.

  • Duke Street Bio Ltd raised $4.1M on May 15, 2026.
  • Portal raised $9M on May 15, 2026.
  • WIRobotics raised $68M (Series B) on May 15, 2026.
  • CREATE Medicines raised $122M (Series B) on May 14, 2026.
  • Degron Therapeutics raised $40M (Series A) on May 14, 2026.
  • Butterfly Medical Ltd raised $21M (Series C) on May 14, 2026.

Who to call at Cadrenal Therapeutics, and when

A new round usually means Cadrenal Therapeutics is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Cadrenal Therapeutics raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Cadrenal Therapeutics, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Cadrenal Therapeutics. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Cadrenal Therapeutics

Location

822 A1A NORTH

Ponte Vedra, Florida, United States

About

Cadrenal Therapeutics is a late-stage biopharmaceutical company developing tecarfarin, an oral therapeutic designed to be a superior and safer Vitamin K antagonist (VKA) anticoagulant for patients with implanted cardiac devices or rare cardiovascular (CV) conditions. Cadrenal strives to improve outcomes and reduce adverse events for these patients such as strokes, heart attacks, bleeds, and deaths. These patients also lack approved chronic anticoagulation options besides warfarin, well-known for its serious side effects and frequent drug-drug interactions, resulting in complicated treatment management.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Cadrenal Therapeutics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

2 contacts
Verified contactsMatthew S., Chief Financial Officer hidden hiddenSee plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for Cadrenal Therapeutics's next move

See what Strategic adds

Cadrenal Therapeutics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.